ATXS icon

Astria Therapeutics
ATXS

Overview Fund Activity

25 hedge funds and large institutions have $15.8M invested in Astria Therapeutics in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
7
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WS
1
Wedbush Securities
California
$534K
2
VF
2
Virtu Financial
New York
$281K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$721K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$372K
5
OC
5
Oppenheimer & Co
New York
$358K

Top Sellers

1
RPAM
1
Rhenman & Partners Asset Management
Sweden
$0
2
ARTA
2
A.R.T. Advisors
New York
$101K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$0
4
PAM
4
Panagora Asset Management
Massachusetts
$58K
5
Deutsche Bank
5
Deutsche Bank
Germany
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
– – -15,211 Closed
Deutsche Bank
27
Deutsche Bank
Germany
– – -5,600 Closed
AIM
28
Acrospire Investment Management
Illinois
– – -3,980 Closed
TRCT
29
Tower Research Capital (TRC)
New York
$0 13 -1,413 -99%
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– – -799 Closed
1
2